Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sanofi-Aventis S.A. ADR (SNY)

Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria

Sanofi SNY and partner Regeneron REGN announced that the FDA has accepted their resubmitted supplemental biologics license application (sBLA) seeking approval of Dupixent for the treatment of chronic spontaneous...

GILD : 89.76 (+1.27%)
REGN : 744.50 (+0.15%)
PFE : 25.13 (+0.76%)
SNY : 47.98 (+0.42%)
Vaccine Stocks Slide, Psychedelic Stocks Surge After RFK Jr. HHS Nomination

Markets sent a clear message Friday following President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to head the Department of Health and Human Services (HHS). Vaccine stocks took a nosedive,...

CMPS : 4.45 (-4.61%)
PSIL : 11.91 (-0.82%)
ATAI : 1.5200 (-4.40%)
AZN : 64.26 (+1.68%)
BVNRY : 8.9500 (-0.83%)
NVAX : 8.04 (-0.25%)
MRNA : 38.25 (+3.55%)
CYBN : 10.16 (-8.96%)
GSK : 33.70 (+1.05%)
PFE : 25.13 (+0.76%)
BNTX : 108.23 (+5.96%)
SNY : 47.98 (+0.42%)
Trump Names Anti-Vaxxer Robert Kennedy As Health & Human Services Secretary: Here’s What It Means For Healthcare Stocks

Trump said his HHS Secretary nominee will ensure the public is protected from harmful substances that have aggravated the nation’s health crisis.

NVO : 102.63 (-2.51%)
IBB : 136.10 (+0.93%)
LLY : 749.92 (-0.46%)
MRNA : 38.25 (+3.55%)
AMGN : 289.90 (+0.71%)
XBI : 94.30 (+0.31%)
PFE : 25.13 (+0.76%)
BNTX : 108.23 (+5.96%)
SNY : 47.98 (+0.42%)
Top Analyst Reports for UnitedHealth, Bank of America & SAP

Wednesday, November 13, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth...

SONY : 19.07 (-0.57%)
SAP : 236.03 (+0.43%)
BAC : 46.46 (+0.87%)
BSX : 91.50 (+1.47%)
UNH : 597.49 (-0.50%)
SNY : 47.98 (+0.42%)
AstraZeneca Beats on Q3 Earnings, Ups 2024 View, to Invest $3.5B in US

AstraZeneca’s AZN third-quarter 2024 core earnings of $1.04 per American depositary share (ADS) beat the Zacks Consensus Estimate of $1.01 per share. Core earnings of $2.08 per share fell 20% year over...

AZN : 64.26 (+1.68%)
AMGN : 289.90 (+0.71%)
SNY : 47.98 (+0.42%)
Buy, Sell, or Hold AstraZeneca Stock? Key Tips Ahead of Q3 Earnings

Key TakeawaysZacks earnings estimates for AstraZeneca are currently at $4.06 per share. However, the earnings picture appears to brighten in 2025.The healthcare company has beaten earnings estimates in...

AZN : 64.26 (+1.68%)
NVO : 102.63 (-2.51%)
LLY : 749.92 (-0.46%)
SNY : 47.98 (+0.42%)
REGN Q3 Earnings and Revenues Beat on Strong Eylea HD & Dupixent Sales

Regeneron Pharmaceuticals, Inc. REGN reported better-than-expected third-quarter results despite lower sales from its lead drug, Eylea. Revenues climbed 11% to $3.72 billion, driven by growth in Eylea...

BAYRY : 5.0900 (-0.97%)
NVS : 103.85 (+0.74%)
REGN : 744.50 (+0.15%)
SNY : 47.98 (+0.42%)
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split

One of these players has split its stock in the past. The other one hasn't.

NVDA : 146.67 (+0.53%)
LLY : 749.92 (-0.46%)
GS : 596.11 (+2.44%)
CMG : 59.98 (+1.87%)
REGN : 744.50 (+0.15%)
AMGN : 289.90 (+0.71%)
WMT : 88.39 (+1.39%)
SNY : 47.98 (+0.42%)
Why Sanofi Stock Flew Higher on Friday

No investor can ignore a crushing bottom-line beat and raised profitability guidance.

SNY : 47.98 (+0.42%)
Pharma Stock Roundup: RHHBY Earnings, Drug Pipeline & Regulatory News

This week, Roche RHHBY announced its third-quarter and nine-month results. Sanofi SNY confirmed that it is holding exclusive talks with U.S. private equity company CD&R to sell a controlling stake in its...

AZN : 64.26 (+1.68%)
NVO : 102.63 (-2.51%)
RHHBY : 35.2900 (+0.46%)
PFE : 25.13 (+0.76%)
SNY : 47.98 (+0.42%)

Barchart Exclusives

Up 99% in the Past Year, How High Can This Growth Stock Rise?
With Lumentum shares skyrocketing over the past year, can this growth stock keep climbing? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar